Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice.
The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice. Cancer Lett. 2004 Jun 25; 209(2):165-9.
View in:
PubMed
subject areas
Acetanilides
Adenomatous Polyposis Coli
Alleles
Animals
Carcinogens
Disease Progression
Dose-Response Relationship, Drug
Enzyme Inhibitors
Genes, APC
Injections, Intraperitoneal
Intestinal Neoplasms
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Neoplasm Invasiveness
Piperazines
Ranolazine
authors with profiles
Rudolph Navari